0001013594-20-000496.txt : 20200514 0001013594-20-000496.hdr.sgml : 20200514 20200514182555 ACCESSION NUMBER: 0001013594-20-000496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paulson John CENTRAL INDEX KEY: 0001394923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 20879721 MAIL ADDRESS: STREET 1: 1133 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml X0306 4 2020-05-12 0000885590 Bausch Health Companies Inc. BHC 0001394923 Paulson John 1133 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10036 true Common Stock, no par value 2020-05-12 4 P 0 25000 17.3 A 20864035 I By Managed Funds Common Stock, no par value 2020-05-12 4 P 0 162900 17.5 A 21026935 I By Managed Funds Common Stock, no par value 2020-05-12 4 P 0 374836 17.33 A 21401771 I By Managed Funds Common Stock, no par value 2020-05-12 4 P 0 678400 17.47 A 22080171 I By Managed Funds Common Stock, no par value 2020-05-12 4 P 0 799900 17.24 A 22880071 I By Managed Funds Common Stock, no par value 2020-05-13 4 P 0 603900 16.32 A 23483971 I By Managed Funds Common Stock, no par value 2020-05-13 4 P 0 80300 16.58 A 23564271 I By Managed Funds Common Stock, no par value 2020-05-13 4 P 0 645844 16.7 A 24210115 I By Managed Funds Common Stock, no par value 2020-05-14 4 P 0 348920 15.85 A 24559035 I By Managed Funds Common Stock, no par value 2020-05-14 4 P 0 70000 15.65 A 24629035 I By Managed Funds Common Stock, no par value 2020-05-14 4 P 0 624900 15.87 A 25253935 I By Managed Funds Common Stock, no par value 2020-05-14 4 P 0 585100 15.92 A 25839035 I By Managed Funds John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. /s/ John Paulson 2020-05-14